Medication info
Hiroten Tablet 5/100 Milligram (Amlodipine, Losartan Potassium)

Hiroten Tablet 5/100 Milligram (Amlodipine, Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›100mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
Pale pink rectangular film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201502665 · Approved 2015.04.30

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy and stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into consideration baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination product compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with decreased effective intravascular volume: Administration of this medicine is not recommended in a small number of patients with decreased effective intravascular volume (e.g., patients receiving treatment with high-dose diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: For patients aged 75 years or older, an initial losartan dose of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Child dose
○ Pediatric patients: Use of this drug is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy and stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medicine is used in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with either amlodipine or losartan. Additionally, it is used as a first-line treatment for patients with stage 2 hypertension who require combination therapy to reach the target blood pressure. In other words, it helps to effectively manage hypertension and stabilize blood pressure.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into consideration baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination product compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with decreased effective intravascular volume: Administration of this medicine is not recommended in a small number of patients with decreased effective intravascular volume (e.g., patients receiving treatment with high-dose diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: For patients aged 75 years or older, an initial losartan dose of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Child dose

○ Pediatric patients: Use of this drug is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.

Precautions

This drug can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, and in severe cases may lead to death. If pregnancy is confirmed, discontinuation must occur immediately, and women of childbearing potential should not use this drug. Patients with reduced effective circulating blood volume, such as those on diuretics, may experience low blood pressure when initially starting this medication, requiring caution. It should not be administered to patients with known allergies to any of the components, severe liver dysfunction, severe aortic stenosis, or those in a state of shock. As it may cause a drop in blood pressure and dizziness, patients should avoid high-risk activities such as operating dangerous machinery or driving. Patients with pre-existing kidney dysfunction or hyperkalemia should periodically monitor their kidney function and serum potassium levels while using this medication. When taken with other antihypertensive medications, the effect may be enhanced; therefore, it should be managed carefully under the supervision of a specialist. It is advisable to avoid drinking grapefruit juice while taking this medicine, as it may lead to excessive blood pressure lowering effects. If severe allergic reactions or symptoms of angioedema occur while using this medication, immediate medical attention must be sought. This drug is not recommended for breastfeeding women, and safety has not been adequately established for pediatric patients or elderly patients over the age of 75, necessitating caution. In case of overdose, severe hypotension and tachycardia may occur; therefore, adherence to the prescribed dosage is crucial, and any abnormal symptoms should prompt an immediate visit to the hospital. This medication should be stored out of reach of children, and transferring to other containers is not advisable as it may compromise quality.

Side effects

Dizziness, headache, drowsiness, cerebral infarction, weakness, chest discomfort, chest pain, early satiety, peripheral edema, dependant edema, abdominal discomfort, indigestion, nausea, gastroesophageal reflux disease, constipation, itching, urticaria, palpitations, flushing, orthostatic hypotension, facial flushing, dyspnea, cough, conjunctival injection, frequent urination, fatigue, edema, vasculitis, hypertonia, sensory loss, paresthesia, peripheral neuropathy, syncope, dysgeusia, tremor, erectile dysfunction, gynecomastia, changes in bowel habits, dry mouth, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, insomnia, mood changes, rhinitis, hair loss, increased sweating, purpura, skin discoloration, toxic epidermal necrolysis, tinnitus, visual disturbances, increased frequency of urination, urinary disorders, nocturia, hepatitis, jaundice, elevated liver enzymes, pruritus, rash, angioedema, erythema multiforme, myocardial infarction, arrhythmia, hypotension, sinus block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, erythema multiforme-like rash, heaviness in the head, sensation of heat, impaired glucose tolerance, weakness, muscle cramps, low back pain, leg pain, congestion, upper respiratory infection, sinusitis, sinus disorders, pharyngitis, myalgia, edema, anorexia, toothache, flatulence, gastritis, anemia, gout, upper extremity pain, hip pain, joint swelling, knee pain, musculoskeletal pain, shoulder pain, muscle rigidity, arthralgia, arthritis, fibromyalgia, muscle weakness, anxiety, anxiety disorders, ataxia, confusion, depression, nightmares, sensory impairment, reduced libido, memory impairment, migraine, neurodermatitis, panic disorder, sleep disturbances, bronchitis, pharyngeal discomfort, nasal bleeding, respiratory congestion, dermatitis, dry skin, petechial hemorrhage, erythema, photosensitivity, sweating, blurred vision, burning sensation in the eyes and pain, conjunctivitis, taste distortion, tinnitus, decreased vision, urethral infection, angioedema, vasculitis, anaphylactic reaction, liver dysfunction, intestinal vascular edema, lethargy, thrombocytopenia, rhabdomyolysis, dysgeusia, dry cough, erythematous skin syndrome, hyperkalemia, hyponatremia, elevated ALT, increased serum creatinine, elevated liver enzymes or serum bilirubin, syncope, loss of consciousness, acute hepatitis, fulminant hepatitis, anaphylactoid syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to protect it from air and moisture, at a temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the drug's efficacy for a longer period.

Appearance and packaging

Appearance

Pale pink rectangular film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.